Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72

Experimental Cell Research

Volumn 319, Issue 10, 2013, Pages 1451-1462

  Ham, Young Mi ^a,b   Mahoney, Sarah Jane ^b  

^a Korea University   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AKT; Endothelin 1; ERK; Hypertrophy; IGF 1; TRIM72

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN KINASE B; TRIPARTITE MOTIF CONTAINING 72; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DOWN REGULATION; HEART SIZE; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

MUS MUSCULUS; RATTUS;

EID: 84877923964     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.02.016     Document Type: Article

References (29)

1. Richardson R.S. Oxygen transport: Air to muscle cell. Med. Sci. Sport. Exerc. 1998, 30:53-59.
2. Ellison G.M., Waring C.D., Vicinanza C., Torella D. Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. Heart 2012, 98:5-10.
3. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol 2006, 7:589-600.
4. Wang L., Proud C.G. Ras/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes. Circ. Res 2002, 91:821-829.
5. Magnuson B., Ekim B., Fingar D.C. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem. J 2012, 441:1-21.
6. Mendoza M.C., Ekrem E.E., Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends. Biochem. Sci. 2011, 36:320-328.
7. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
8. Tang E.D., Nuñez G., Barr F.G., Guan K.L. Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 1999, 274:16741-16746.
9. McMullen J.R., Shioi T., Zhang L., Tarnavski O., Sherwood M.C., Dorfman A.L., Longnus S., Pende M., Martin K.A., Blenis J., Thomas G., Izumo S. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy. Mol. Cell Biol 2004, 24:6231-6240.
10. Dorn G.W., Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest 2005, 115:527-537.
11. Lee C.S., Yi J.S., Jung S.Y., Kim B.W., Lee N.R., Choo H.J., Jang S.Y., Han J., Chi S.G., Park M., Lee J.H., Ko Y.G. TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1. Cell. Death. Differ 2010, 17:1254-1265.
12. Watkins S.J., Borthwick G.M., Arthur H.M. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell. Dev. Biol.-Animal 2011, 47:125-131.
13. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol. 2006, 7:589-600.
14. Braz J.C., Bueno O.F., De Windt L.J., Molkentin J.D. PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2). J. Cell. Biol. 2002, 156:905-919.
15. Sugden P.H. An overview of endothelin signaling in the cardiac myocyte. J. Mol. Cell. Cardiol 2003, 35:871-886.
16. Cheng T.H., Shih N.L., Chen C.H., Lin H., Liu J.C., Chao H.H., Liou J.Y., Chen Y.L., Tsai H.W., Chen Y.S., Cheng C.F., Chen J.J. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy. J. Biomed. Sci. 2005, 12:123-133.
17. Sugden P.H. Signaling pathways activated by vasoactive peptides in the cardiac myocyte and their role in myocardial pathologies. J. Card. Fail 2002, 8:S359-369.
18. Clerk A., Sugden P.H. Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am. J. Cardiol. 1999, 83:64H-69H.
19. Dimitrijevic I., Edvinsson M.L., Chen Q., Malmsjö M., Kimblad P.O., Edvinsson L. Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease. BMC Cardiovasc. Disord 2009, 25:40.
20. Tanfin Z., Leiber D., Robin P., Oyeniran C., Breuiller-Fouché M. Endothelin-1: physiological and pathological roles in myometrium. Int. J. Biochem. Cell. Biol. 2011, 43:299-302.
21. Nishimoto A., Lu L., Hayashi M., Nishiya T., Horinouchi T., Miwa S. Jab1 regulates levels of endothelin type A and B receptors by promoting ubiquitination and degradation. Biochem. Biophys. Res. Commun. 2010, 391:1616-1622.
22. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol. 2006, 7:589-600.
23. Romeo Y., Zhang X., Roux P.P. Regulation and function of the RSK family of protein kinases. Biochem. J. 2012, 15:553-569.
24. Nagoshi T., Matsui T., Aoyama T., Leri A., Anversa P., Li L., Ogawa W., del Monte F., Gwathmey J.K., Grazette L., Hemmings B.A., Kass D.A., Champion H.C., Rosenzweig A. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J. Clin. Invest. 2005, 115:2128-2138.
25. DeBosch B., Treskov I., Lupu T.S., Weinheimer C., Kovacs A., Courtois M., Muslin A.J. Akt1 is required for physiological cardiac growth. Circulation 2006, 113:2097-2104.
26. Taniyama Y., Ito M., Sato K., Kuester C., Veit K., Tremp G., Liao R., Colucci W.S., Ivashchenko Y., Walsh K., Shiojima I. Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy. J. Mol. Cell. Cardiol. 2005, 38:375-385.
27. Miyazaki M., McCarthy J.J., Fedele M.J., Esser K.A. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signaling. J. Physiol 2011, 589:1831-1846.
28. Markou T., Marshall A.K., Cullingford T.E., Thamel L., Sugden P.H., Clerk A. Regulation of the cardiomyocyte transcriptome vs translatome by endothelin-1 and insulin: translational regulation of 5' terminal oligopyrimidine tract (TOP) mRNAs by insulin. BMC Genomics 2010, 29(11):343.
29. Goshima K. Quabain-induced arrhythmias of single isolated myocardial cells and cell clusters cultured in vitro and their improvement by quinidine. J. Mol. Cell. Cardiol 1977, 9:7-23.